Overview
Lingli Hu practices practicing medicine in Shanghai, China.
Their clinical expertise encompasses Glucocorticoid Resistance, Asthma, and Pulmonary Fibrosis.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lingli Hu
Is Lingli Hu a top-rated expert for Glucocorticoid Resistance?
MediFind is an objective health platform that identifies experts based on real-world data. Lingli Hu is classified as an Experienced expert for Glucocorticoid Resistance, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lingli Hu participate in research or clinical trials?
Yes. Lingli Hu has published 8 articles and abstracts on conditions like Glucocorticoid Resistance. You can view a list of Lingli Hu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AsthmaHu isExperienced. Learn about Asthma.
- Glucocorticoid Resistance
- Pulmonary FibrosisHu isExperienced. Learn about Pulmonary Fibrosis.